Healthcare & Pharmaceuticals

Client Transaction Details Value
(US$ mn)
Max Healthcare Merger of Radiant Life Care 1,200 2018
Dr. Reddy's Laboratories Manager to the Buyback Offer to the shareholders of Dr. Reddy's Laboratories Limited via Open Market route 234 2016
Laurus Labs Book Running Lead Manager for IPO 197 2016
Healthcare Global Enterprises Book Running Lead Manager for IPO 100 2016
TPG Capital Financial Advisor to TPG Capital for investment in Manipal Health Enterprises 150 2015
Dr Lal PathLabs Book Running Lead Manager for IPO 94 2015
Glaxo Smithkline Pharmaceuticals Open Offer for Glaxo Smithkline Pharmaceuticals 1,065 2014
Actis Sale of controlling stake in Sterling Hospitals Undisclosed 2014
Bausch & Lomb Eyecare India Bausch & Lomb Eyecare India Ltd divested its Ophthalmology Portfolio to Ipca Laboratories Ltd Undisclosed 2014
B. Braun Delisting Offer for Ahlcon Parenterals (India) Limited 16 2014
Torrent Pharmaceuticals Acquisition of the Indian formulation business of Elder Pharmaceuticals by Torrent Pharmaceuticals 322 2013
Mitsui – Arch Pharmalabs Limited Mitsui & Co., Ltd. has acquired an additional 27.29% of the shares of Arch Pharmalabs Limited for US$ 68 million taking their post transaction shareholding to 31.96%. Kotak Investment Banking and GCA Savvian Corporation were the Exclusive Financial Advisors to Mitsui & Co., Ltd. for the transaction. 68 2013
Trivitron Healthcare Exclusive financial advisor to Trivitron for private equity investment by Fidelity Growth Partners India 75 2012
Super Religare Laboratories Financial advisor to Super Religare Laboratories for private equity investment by Jacob Ballas and International Finance Corporation (IFC), 67 2012
Super Religare Laboratories Financial advisor for private equity investment in Super Religare Laboratories by Avigo and Sabre Capital 30 2011
Piramal Healthcare Manager to buyback of equity shares 551 2010
Jubilant Organosys Business Restructuring and Fairness Opinion - 2010
Strides Arcolab Book Running Lead Manager for QIP 99.8 2010
Jubilant Organosys Book Running Lead Manager to the QIP 84.8 mn 2010
Cipla Exclusive Advisor to Cipla Limited for acquisition of Meditab Private Limited 29 2010
Cipla Exclusive financial advisor to Cipla for sale of all Intellectual property rights in India related to Cipla's "i-pill" brand to Piramal Healthcare 21 2010
Cipla Qualified Institutional Placement 142 2009
Apollo Hospitals Enterprise Ltd Preferential Allotment of up to 12% stake by Apollo Hospitals Enterprise Ltd to Apax Partners 104 2007
Fortis Initial Public Offering 121 2007
Cipla GDR Issue 170 2006
Vimta Labs Private equity placement with portfolio funds through preferential allotment route 17.4 2006
Apollo Hospitals Enterprise Ltd GDR Issue 70 2005
Nicholas Piramal Rights Issue 76.4 2005